Hengrui Set For Biggest Biopharma IPO So Far This Year

Hong Kong Listing To Raise Up To $1.27bn

 
• By Dexter Jie Yan
  
IPO
Hengrui to gross up to $1.27bn from initial public offering in Hong Kong SAR • Source: Shutterstock: stavklem
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Financing